Cargando…
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
The development of efficacious antitumor compounds with minimal toxicity is a hot research topic. Numerous cancer cell targeted agents are evaluated daily in laboratories for their antitumorigenicity at the pre-clinical level, but the process of their introduction into the market is costly and time-...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932542/ https://www.ncbi.nlm.nih.gov/pubmed/27164115 http://dx.doi.org/10.3390/ph9020024 |